The treatment of attention-deficit hyperactivity disorder with methylphenidate
Mark L. Wolraich
Abstract
Mark L. Wolraich
Abstract
This article reviews the recent advances in our understanding of methylphenidate and its use in children with attention-deficit hyperactivity disorder. It begins by reviewing the diagnostic issues important in deciding who should be treated with methylphenidate. The two main issues concern the current criteria for diagnosing attention-deficit hyperactivity disorder and the impact of comorbid conditions. This is followed by a review of recent literature about the effects of methylphenidate. The primary focus is on some of the effects of the drug on cognition. Lastly, the side effects are reviewed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This article reviews the recent advances in our understanding of methylphenidate and its use in children with attention-deficit hyperactivity disorder. It begins by reviewing the diagnostic issues important in deciding who should be treated with methylphenidate. The two main issues concern the current criteria for diagnosing attention-deficit hyperactivity disorder and the impact of comorbid conditions. This is followed by a review of recent literature about the effects of methylphenidate. The primary focus is on some of the effects of the drug on cognition. Lastly, the side effects are reviewed.
Key concepts: Methylphenidate, Attention deficit hyperactivity disorder, Attention deficit disorder, Attention deficit, Psychiatry, Psychology, Cognition, Medicine